Health Technology Assessments (HTA)
The Norwegian Institute of Public Health contributes to national and international Health Technology Assessments.
Reports
Projects
- Disinvestment of medical technologies in Specialist Healthcare Services
- Safety, clinical effectiveness, diagnostic accuracy and cost effectiveness of blood-based tests for women with suspected pre-eclampsia
- Health Technology Assessment of medicines, including rituximab, used for primary progressive multiple sclerosis (PPMS)
- Health Technology Assessment of medicines used for multiple sclerosis
- Hyperbaric oxygen therapy for osteonecrosis - project plan
